Generation and optimization of a chimeric antigen receptor against human CD22: A new immunotherapeutic agent for adoptive immunotherapy

被引:0
|
作者
Haso, Waleed [1 ]
Lee, Daniel [1 ]
Morgan, Richard [1 ]
Pastan, Ira [1 ]
Mackall, Crystal [1 ]
Orentas, Rimas J. [1 ]
机构
[1] NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1158/1538-7445.AM2012-3504
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3504
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Wang, Yiyun
    Yang, Yingying
    Hong, Ruimin
    Zhao, Houli
    Wei, Guoqing
    Wu, Wenjun
    Xu, Huijun
    Cui, Jiazhen
    Zhang, Yanlei
    Chang, Alex H.
    Hu, Yongxian
    Huang, He
    BLOOD CANCER JOURNAL, 2020, 10 (10)
  • [32] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Yiyun Wang
    Yingying Yang
    Ruimin Hong
    Houli Zhao
    Guoqing Wei
    Wenjun Wu
    Huijun Xu
    Jiazhen Cui
    Yanlei Zhang
    Alex H. Chang
    Yongxian Hu
    He Huang
    Blood Cancer Journal, 10
  • [33] Nanobody-based anti-CD22-chimeric antigen receptor T cell immunotherapy exhibits improved remission against B-cell acute lymphoblastic leukemia
    Zhang, Tingting
    Wang, Tian
    You, Fengtao
    Li, Zixuan
    Chen, Dan
    Zhang, Kailu
    Tian, Shuaiyu
    Sheng, Binjie
    Wu, Hai
    Jiang, Licui
    Ma, Renyuxue
    An, Gangli
    Meng, Huimin
    Yang, Lin
    TRANSPLANT IMMUNOLOGY, 2022, 71
  • [34] Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis
    Komal Adeel
    Nathan J. Fergusson
    Risa Shorr
    Harold Atkins
    Kevin A. Hay
    Systematic Reviews, 10
  • [35] Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis
    Adeel, Komal
    Fergusson, Nathan J.
    Shorr, Risa
    Atkins, Harold
    Hay, Kevin A.
    SYSTEMATIC REVIEWS, 2021, 10 (01)
  • [36] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Aiyun Jin
    Jingjing Feng
    Guoqing Wei
    Wenjun Wu
    Luxin Yang
    Huijun Xu
    Yanlei Zhang
    Jiazhen Cui
    Alex Hongsheng Chang
    Yongxian Hu
    He Huang
    Bone Marrow Transplantation, 2020, 55 : 717 - 721
  • [37] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Jin, Aiyun
    Feng, Jingjing
    Wei, Guoqing
    Wu, Wenjun
    Yang, Luxin
    Xu, Huijun
    Zhang, Yanlei
    Cui, Jiazhen
    Chang, Alex Hongsheng
    Hu, Yongxian
    Huang, He
    BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 717 - 721
  • [39] Adoptive Immunotherapy for B-cell Malignancies Using CD19-Targeted Chimeric Antigen Receptor T-Cells: A Systematic Review of Efficacy and Safety
    Hao, Lu
    Li, Tongtong
    Chang, Lung-Ji
    Chen, Xiaochuan
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (17) : 3068 - 3079
  • [40] Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells
    Karschnia, Philipp
    Arrillaga-Romany, Isabel C.
    Eichler, April
    Forst, Deborah A.
    Gerstner, Elizabeth
    Jordan, Justin T.
    Ly, Ina
    Plotkin, Scott R.
    Wang, Nancy
    Martinez-Lage, Maria
    Winter, Sebastian F.
    Tonn, Joerg-Christian
    Rejeski, Kai
    von Baumgarten, Louisa
    Cahill, Daniel P.
    Nahed, Brian, V
    Shankar, Ganesh M.
    Abramson, Jeremy S.
    Barnes, Jeffrey A.
    El-Jawahri, Areej
    Hochberg, Ephraim P.
    Johnson, P. Connor
    Soumerai, Jacob D.
    Takvorian, Ronald W.
    Chen, Yi-Bin
    Frigault, Matthew J.
    Dietrich, Jorg
    NEURO-ONCOLOGY, 2023, 25 (12) : 2239 - 2249